India’s CRAMS Face Reduced Clientele Through Global M&As
This article was originally published in PharmAsia News
Executive Summary
India's contract drug-manufacturing-and-research services face a reduced clientele list as the number of pharmaceutical companies contract through mergers and acquisitions